ETF Copilot

IHE vs XPH: holdings overlap, shared companies and scores

As of October 28, 2026, IHE and XPH overlap 40.0% by weight. iShares U.S. Pharmaceuticals ETF (IHE): U.S. pharmaceutical manufacturers. State Street SPDR S&P Pharmaceuticals ETF (XPH): U.S. pharmaceutical companies.

Updated October 28, 2026

Where IHE and XPH trade against their own history

IHE trades at 29.7 times earnings, against its own median of 22.9, and is more expensive than 99% of its own last 9 years.

XPH trades at 15.4 times earnings, against its own median of 18.8, and is cheaper than 81% of its own last 6 years.

What moved IHE and XPH this week

IHE rose 0.9% in the week to October 28, 2026. The holdings that moved it most were Johnson & Johnson (+5.1%), Eli Lilly (+1.4%) and Royalty Pharma (+4.3%); Corcept Therapeutics (−25.8%) pushed the other way.

XPH rose 0.9% in the week to October 28, 2026. The holdings that moved it most were Liquidia (+17.7%), Septerna (+8.6%) and Omeros (+10.0%); Corcept Therapeutics (−25.8%) pushed the other way.

What do IHE and XPH each hold?

80% of IHE is its ten largest holdings.

24% of XPH is its ten largest holdings.

How much do IHE and XPH overlap? 40.0% by weight

As of October 28, 2026, IHE and XPH overlap 40.0% by weight.

100% of IHE is already inside XPH.

92% of XPH is already inside IHE.

IHE holds 56 companies and XPH holds 62; 53 are in both.

Computed by ETF Copilot from both funds' holdings rather than quoted from a data provider, and rebuilt nightly.

How does ETF Copilot score IHE and XPH? 6.0 and 4.7 out of 10

As of October 28, 2026, ETF Copilot scores IHE 6.0 out of 10 and XPH 4.7 out of 10.

They differ most on Value: IHE 1.8 and XPH 9.8.

The five factor scores behind them are set out below, 0–10 and higher is better, ranked against every US equity ETF we track.

IHE vs XPH — ETF Copilot factor scores, 0–10
FactorIHEXPH
Growth5.15.0
Value1.89.8
Risk7.63.3
Quality8.91.9
Return6.73.9

XPH is the cheaper of the two at 0.35% a year

As of October 28, 2026, IHE charges 0.37% a year, yields 1.37% and holds $1.6B in assets across 56 positions.

As of October 28, 2026, XPH charges 0.35% a year, yields 0.42% and holds $448M in assets across 62 positions.

IHE vs XPH — cost, income and size
MeasureIHEXPH
Expense ratio0.37%0.35%
Dividend yield1.37%0.42%
Assets under management$1.6B$448M
Holdings5662

Expense ratio, dividend yield and assets under management are reported by the fund and refreshed daily. Every other figure on this page is computed by ETF Copilot.

Cite this

ETF Copilot, “IHE vs XPH holdings overlap and scores”, as of October 28, 2026.
https://etf-copilot.com/compare/ihe-vs-xph

  1. iShares U.S. Pharmaceuticals ETF (IHE)
  2. State Street SPDR S&P Pharmaceuticals ETF (XPH)

ETF Copilot Pro unlocks IHE vs XPH prices and holdings.

Try Pro free →